<p>(A) Decreasing glucose concentration leads to increased proliferation of cells lacking mtDNA. Strain BY4742 (<i>WT</i>) was cultured in YEPD medium containing 2%, 0.5%, or 0.2% glucose and tested for the response to mtDNA deletion. Cells were incubated for 3 d. (B) Proliferation of <i>ρ</i><sup><i>0</i></sup> cells by Gpa2p or Gpr1p deletion is not improved further upon lowering the glucose concentration. Strains BY4742 (<i>WT</i>), CDD849 (<i>gpa2Δ</i>), and CDD850 (<i>gpr1Δ</i>) were treated as in (A), yet incubated on solid medium for 2 d.</p
Pathological variants of human mitochondrial DNA (mtDNA) typically co-exist with wild-type molecules...
<p>VM-M3 cells were grown in conditions mimicking metabolic therapy, including combinations of varie...
<p>A549 cells were transfected with control (Ctr) and Rheb vector for 8 h respectively, and then tre...
<p>Cells were exposed to medium with glucose concentrations varying from 5.5 to 50 mM for 12, 24, or...
<p>(A) Overexpression of cAMP phosphodiesterase Pde2p increases the fitness of cells lacking mtDNA. ...
<div><p>Damage to the mitochondrial genome (mtDNA) can lead to diseases for which there are no clear...
Damage to the mitochondrial genome (mtDNA) can lead to diseases for which there are no clearly effec...
<p>(A) MDA-MB-231 cells were grown for 72 hours in high-glucose (4.5 g/L), low-glucose (1 g/L) and g...
<p>A, mitochondrial DNA and genomic DNA were evaluated by PCR from total DNA isolated from the indic...
The aim of this study was to develop an in vitro model to in-vestigate the molecular mechanisms of g...
Mesenchymal stem cells (MSCs) show great promise for use in a variety of cell-based therapies. Becau...
<p>Seventy two hours post transfection cells were stimulated with basal (3 mM) or high (25 mM) gluco...
<p>(A) Growth curves and Western Blots showing changes in DnaA and CtrA levels after shifting wild t...
<p>The change in proliferation rate was analyzed by MTT assay (A). Both p-STAT3/t-STAT3 and GRIM-19 ...
<p>MDA-MB-231 and MBA-MD-468 cells were exposed to VCD treatment in cell culture. (A) Cells were tre...
Pathological variants of human mitochondrial DNA (mtDNA) typically co-exist with wild-type molecules...
<p>VM-M3 cells were grown in conditions mimicking metabolic therapy, including combinations of varie...
<p>A549 cells were transfected with control (Ctr) and Rheb vector for 8 h respectively, and then tre...
<p>Cells were exposed to medium with glucose concentrations varying from 5.5 to 50 mM for 12, 24, or...
<p>(A) Overexpression of cAMP phosphodiesterase Pde2p increases the fitness of cells lacking mtDNA. ...
<div><p>Damage to the mitochondrial genome (mtDNA) can lead to diseases for which there are no clear...
Damage to the mitochondrial genome (mtDNA) can lead to diseases for which there are no clearly effec...
<p>(A) MDA-MB-231 cells were grown for 72 hours in high-glucose (4.5 g/L), low-glucose (1 g/L) and g...
<p>A, mitochondrial DNA and genomic DNA were evaluated by PCR from total DNA isolated from the indic...
The aim of this study was to develop an in vitro model to in-vestigate the molecular mechanisms of g...
Mesenchymal stem cells (MSCs) show great promise for use in a variety of cell-based therapies. Becau...
<p>Seventy two hours post transfection cells were stimulated with basal (3 mM) or high (25 mM) gluco...
<p>(A) Growth curves and Western Blots showing changes in DnaA and CtrA levels after shifting wild t...
<p>The change in proliferation rate was analyzed by MTT assay (A). Both p-STAT3/t-STAT3 and GRIM-19 ...
<p>MDA-MB-231 and MBA-MD-468 cells were exposed to VCD treatment in cell culture. (A) Cells were tre...
Pathological variants of human mitochondrial DNA (mtDNA) typically co-exist with wild-type molecules...
<p>VM-M3 cells were grown in conditions mimicking metabolic therapy, including combinations of varie...
<p>A549 cells were transfected with control (Ctr) and Rheb vector for 8 h respectively, and then tre...